Evaluation of central auditory discrimination abilities in older adults.Association of Low Lean Mass With Frailty and Physical Performance: A Comparison Between Two Operational Definitions of Sarcopenia-Data From the Berlin Aging Study II (BASE-II).Identifying Sarcopenia in Metabolic Syndrome: Data from the Berlin Aging Study II.Higher Lipoprotein (a) Levels Are Associated with Better Pulmonary Function in Community-Dwelling Older People - Data from the Berlin Aging Study II.Lung function in elderly subjects with metabolic syndrome and type II diabetes : Data from the Berlin Aging Study II.[Pulmonary function in elderly subjects with metabolic syndrome and type II diabetes : Data from the Berlin Aging Study II].Sports and Exercise at Different Ages and Leukocyte Telomere Length in Later Life--Data from the Berlin Aging Study II (BASE-II)Leukocyte telomere length is related to appendicular lean mass: cross-sectional data from the Berlin Aging Study II (BASE-II).Relative Leukocyte Telomere Length, Hematological Parameters and Anemia - Data from the Berlin Aging Study II (BASE-II).Association between Metabolic Syndrome and Bone Mineral Density--Data from the Berlin Aging Study II (BASE-II).Angiotensin-Converting Enzyme Inhibitors and Parameters of Sarcopenia: Relation to Muscle Mass, Strength and Function: Data from the Berlin Aging Study-II (BASE-II).The correlation between waist circumference and ESC cardiovascular risk score: data from the German metabolic and cardiovascular risk project (GEMCAS).Dyslipidemia in primary care--prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).Clinical utility gene card for: hyperlipoproteinemia, TYPE II.Genome-wide association study identifies 74 loci associated with educational attainment.Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.Mining geriatric assessment data for in-patient fall prediction models and high-risk subgroups.Two-wave longitudinal findings from the Berlin aging study: introduction to a collection of articles.Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.Prevalence and definition of sarcopenia in community dwelling older people. Data from the Berlin aging study II (BASE-II).Psychological and sociodemographic predictors of premature discontinuation of a 1-year multimodal outpatient weight-reduction program: an attrition analysis.The inflammatory markers CRP, IL-6, and IL-10 are associated with cognitive function--data from the Berlin Aging Study II.Severe hypertriglyceridemia in a patient heterozygous for a lipoprotein lipase gene allele with two novel missense variantsFamilial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis.Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitisProlonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS studyNew loci for body fat percentage reveal link between adiposity and cardiometabolic disease riskPrevalence of obesity in primary care using different anthropometric measures--results of the German Metabolic and Cardiovascular Risk Project (GEMCAS)Sleep, Muscle Mass and Muscle Function in Older PeopleMANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.ICT-based health information services for elderly people: past experiences, current trends, and future strategies.Sex-specific and inter-individual differences in biomarkers of selenium status identified by a calibrated ELISA for selenoprotein P.Whole-body vibration to prevent intensive care unit-acquired weakness: safety, feasibility, and metabolic response.Physical fitness training in Subacute Stroke (PHYS-STROKE)--study protocol for a randomised controlled trial.Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial.PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.SmartSenior@home: Acceptance of an integrated ambient assisted living system. Results of a clinical field trial in 35 households.Exercise at Different Ages and Appendicular Lean Mass and Strength in Later Life: Results From the Berlin Aging Study II.
P50
Q30475488-43551119-9742-47B0-9359-DB7DCF70C5DAQ30886859-4B933DBD-1558-452B-B27E-EE501BAA7383Q30986817-1B87F552-460E-488D-8670-02677BE0D42BQ30999453-91AAA6A6-4C9F-413A-A675-F8957B61769BQ31012073-09702422-3FA4-42D7-A5BB-CB3EBFBB14E9Q31012080-91C0B84A-E702-4850-A1C1-414AE0F9C5C7Q31029927-F3496993-46F8-4C69-ACAD-04639165EE29Q31032487-593DA84C-DD4B-40AF-A2A7-F8094EAF848AQ31040750-13BA8661-E1D4-4300-B2DF-E6C17681A570Q31040771-D2298FAE-5BA6-4437-BD33-D3FBF8ACAEC2Q31132903-BA7DD70D-11A7-4388-B34E-4A22639BC9A0Q31164717-54E093C1-004C-433D-BF95-B2ABFB5D5F1AQ33376862-48549E24-A552-4328-81E7-A5EE8F160E2CQ33765255-84C9B2B3-1028-4734-8291-D3AEBC3FAC87Q34046898-568BB945-5435-4F67-B07A-70C9BA98F3B8Q34071937-546B147C-6016-40E1-8439-137C938D29B1Q34195339-898E1798-1B60-43A3-BCAA-08721CD53F27Q34994014-EAF63858-B651-4F33-9AD7-F508A089BE4CQ35130714-0B185696-FFCB-466A-B029-19D909A91662Q35602843-5C87C171-E114-4FE9-B0E1-969C293FD9B7Q35839720-E1BFB502-C1F4-41B1-8831-7728D1899062Q35909144-020C6900-555B-478C-913F-A8F0E5037FCAQ35959728-E77D520E-09E9-49FD-AFE4-D41D2BA31988Q36076131-0E2E1184-2E6B-4538-A136-08706D613BA7Q36233594-F1BAD1A9-2020-446C-A5F4-E59F975D712AQ36469043-4A6A39B1-0352-472C-889D-35ED75F0F849Q36474506-D3A4AC9A-6DBB-451F-AACE-E26C5C092E50Q36536280-4CA22ABE-1CAB-4B07-B75B-FAE4EEB5EC0CQ36541220-54AC4023-01D1-4F9D-9D20-48DEFFF422E9Q36843852-81C044B0-A181-4F48-A5F3-4E0B415CDB65Q36882862-B447F61E-8C63-4742-B8DD-8E77963508CAQ36904914-00AE43F8-A857-4690-A5DE-EBF0A7658F75Q37029046-5E88F7BE-975E-4D40-8784-83BDCC605DCEQ37570686-8ECCFC09-9137-4C83-B061-1914E21C9ED8Q37572090-53B133A1-4217-4064-9B8A-AB09E48E4990Q37580612-5960942E-8E16-49FF-930C-05DCFB099651Q37584256-752153F3-C14F-457B-A8F1-E1AC41FC05A9Q37607330-B1CCC793-1001-46AC-AFC7-D89A60720A2BQ38383316-BCC4F872-6DDE-44A7-AE09-3EFDC364C5E8Q38386164-FB949A72-A5E2-4B71-AB3D-7D1A351E1944
P50
description
Duits interniste
@nl
German internist
@en
deutsche Medizinerin
@de
dochtúir Gearmánach
@ga
tysk professor
@da
tysk professor
@sv
name
Elisabeth Steinhagen-Thiessen
@ast
Elisabeth Steinhagen-Thiessen
@ca
Elisabeth Steinhagen-Thiessen
@da
Elisabeth Steinhagen-Thiessen
@de
Elisabeth Steinhagen-Thiessen
@en
Elisabeth Steinhagen-Thiessen
@es
Elisabeth Steinhagen-Thiessen
@fr
Elisabeth Steinhagen-Thiessen
@it
Elisabeth Steinhagen-Thiessen
@nds
Elisabeth Steinhagen-Thiessen
@nl
type
label
Elisabeth Steinhagen-Thiessen
@ast
Elisabeth Steinhagen-Thiessen
@ca
Elisabeth Steinhagen-Thiessen
@da
Elisabeth Steinhagen-Thiessen
@de
Elisabeth Steinhagen-Thiessen
@en
Elisabeth Steinhagen-Thiessen
@es
Elisabeth Steinhagen-Thiessen
@fr
Elisabeth Steinhagen-Thiessen
@it
Elisabeth Steinhagen-Thiessen
@nds
Elisabeth Steinhagen-Thiessen
@nl
prefLabel
Elisabeth Steinhagen-Thiessen
@ast
Elisabeth Steinhagen-Thiessen
@ca
Elisabeth Steinhagen-Thiessen
@da
Elisabeth Steinhagen-Thiessen
@de
Elisabeth Steinhagen-Thiessen
@en
Elisabeth Steinhagen-Thiessen
@es
Elisabeth Steinhagen-Thiessen
@fr
Elisabeth Steinhagen-Thiessen
@it
Elisabeth Steinhagen-Thiessen
@nds
Elisabeth Steinhagen-Thiessen
@nl
P106
P214
P227
P1412
P1559
Elisabeth Steinhagen-Thiessen
@de
P19
P21
P213
0000 0000 0896 8877
P214
P227
P31
P512
P569
1946-09-06T00:00:00Z
P735
P7859
viaf-7962628